GWAS-related eQTLs across different cancer types
We identified 337,131 eQTLs that overlap with GWAS linkage disequilibrium (LD) regions (r² ≥ 0.5).
|
Cancer type
|
eQTL type
|
tagSNP
|
Gene position (hg19)
|
p-value
|
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| BLCA | cis | rs1577917 | 1 | rs12205336 | chr6:86722367 | SNHG5 | chr6:86386726-86388451:- | -0.53 | -9.35 | 7.51E-19 | Response to antipsychotic treatment |
| BLCA | cis | rs1577917 | 1 | rs12205548 | chr6:86759770 | SNHG5 | chr6:86386726-86388451:- | -0.53 | -9.25 | 1.56E-18 | Response to antipsychotic treatment |
| BLCA | cis | rs1577917 | 1 | rs12207305 | chr6:86723502 | SNHG5 | chr6:86386726-86388451:- | -0.54 | -9.4 | 5.22E-19 | Response to antipsychotic treatment |
| BLCA | cis | rs1577917 | 1 | rs12207610 | chr6:86688016 | SNHG5 | chr6:86386726-86388451:- | -0.5 | -8.87 | 2.81E-17 | Response to antipsychotic treatment |
| BLCA | cis | rs1577917 | 1 | rs12208493 | chr6:86662267 | SNHG5 | chr6:86386726-86388451:- | -0.53 | -9.22 | 1.97E-18 | Response to antipsychotic treatment |
| BLCA | cis | rs1577917 | 1 | rs12209127 | chr6:86724427 | SNHG5 | chr6:86386726-86388451:- | -0.53 | -9.35 | 7.51E-19 | Response to antipsychotic treatment |
| BLCA | cis | rs1577917 | 1 | rs12212733 | chr6:86726013 | SNHG5 | chr6:86386726-86388451:- | -0.53 | -9.38 | 5.71E-19 | Response to antipsychotic treatment |
| BLCA | cis | rs1577917 | 1 | rs12213149 | chr6:86668644 | SNHG5 | chr6:86386726-86388451:- | -0.53 | -9.22 | 1.97E-18 | Response to antipsychotic treatment |
| BLCA | cis | rs1577917 | 1 | rs12213740 | chr6:86656733 | SNHG5 | chr6:86386726-86388451:- | -0.51 | -9.05 | 7.12E-18 | Response to antipsychotic treatment |
| BLCA | cis | rs1577917 | 1 | rs12215037 | chr6:86727631 | SNHG5 | chr6:86386726-86388451:- | -0.54 | -9.39 | 5.34E-19 | Response to antipsychotic treatment |
| BLCA | cis | rs1577917 | 1 | rs12215903 | chr6:86675028 | SNHG5 | chr6:86386726-86388451:- | -0.5 | -8.81 | 4.46E-17 | Response to antipsychotic treatment |
| BLCA | cis | rs1577917 | 1 | rs12216203 | chr6:86675301 | SNHG5 | chr6:86386726-86388451:- | -0.53 | -9.3 | 1.08E-18 | Response to antipsychotic treatment |
| BLCA | cis | rs1577917 | 1 | rs12216328 | chr6:86703418 | SNHG5 | chr6:86386726-86388451:- | -0.52 | -9.26 | 1.43E-18 | Response to antipsychotic treatment |
| BLCA | cis | rs12220238 | 1 | rs12220238 | chr10:75952670 | ADK | chr10:75910965-76469059:+ | 0.31 | 4.65 | 4.62E-6 | Soluble interleukin-2 receptor subunit alpha |
| BLCA | cis | rs12220238 | 1 | rs12220238 | chr10:75952670 | AP3M1 | chr10:75880016-75910826:- | 0.3 | 3.91 | 0.000107 | Soluble interleukin-2 receptor subunit alpha |